People
Adam Robison focuses on a wide range of matters involving healthcare providers and suppliers. A partner in our Healthcare practice, Adam represents healthcare clients in a variety of regulatory and transactional matters.
Adam represents public and private hospital systems, academic medical centers, medical schools, children's hospitals, hospices, laboratories, physicians and suppliers in various regulatory and transactional matters.
Adam counsels clients concerning False Claims Act and Civil Monetary Penalty investigations, fraud and abuse, along with anti-kickback and physician self-referral issues, including physician contracting. He has also worked with clients on Medicare and Medicaid administrative overpayment appeals; Medicare and Medicaid self-disclosures; and compliance with the 60-day overpayment rule; as well as on Medicaid supplemental payment and 1115 Waiver programs.
In addition, Adam advises clients on a variety of transactional matters, including hospital joint operating company agreements, merger and acquisition agreements, and academic affiliation agreements.
J.D., South Texas College of Law, summa cum laude
B.S., Brigham Young University
Texas
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
June 1, 2022
Chambers USA 2022 Recognizes 188 K&S Lawyers and 75 K&S Practice Groups as Leaders in Their Fields
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
Litigation/Administrative Appeals
Successfully represented a large healthcare company in obtaining an $18 million arbitration award against the sellers of a hospice pursuant to claims for indemnification and fraud related to a self-disclosure audit that Adam also facilitated.
Successfully represented a drug testing laboratory in reducing a $31 million Medicare overpayment resulting in more than a $29 million overpayment reduction.
Represented an oncologist before the Administrative Law Judge in a Medicare overpayment case resulting in the full reversal of the alleged multimillion-dollar overpayment.
See more
November 30, 2020
Major Changes Finalized to Stark Rules, Anti-Kickback Statute Safe Harbors and the Beneficiary Inducements CMP
April 17, 2017
Health Headlines – April 17, 2017
February 20, 2017
Health Headlines – February 20, 2017
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
June 1, 2022
Chambers USA 2022 Recognizes 188 K&S Lawyers and 75 K&S Practice Groups as Leaders in Their Fields
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
Litigation/Administrative Appeals
Successfully represented a large healthcare company in obtaining an $18 million arbitration award against the sellers of a hospice pursuant to claims for indemnification and fraud related to a self-disclosure audit that Adam also facilitated.
Successfully represented a drug testing laboratory in reducing a $31 million Medicare overpayment resulting in more than a $29 million overpayment reduction.
Represented an oncologist before the Administrative Law Judge in a Medicare overpayment case resulting in the full reversal of the alleged multimillion-dollar overpayment.
See more
November 30, 2020
Major Changes Finalized to Stark Rules, Anti-Kickback Statute Safe Harbors and the Beneficiary Inducements CMP
April 17, 2017
Health Headlines – April 17, 2017
February 20, 2017
Health Headlines – February 20, 2017
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
June 1, 2022
Chambers USA 2022 Recognizes 188 K&S Lawyers and 75 K&S Practice Groups as Leaders in Their Fields
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
J.D., South Texas College of Law, summa cum laude
B.S., Brigham Young University
Texas